AI-generated summary
The authors systematically searched for randomized controlled trials of treatments for hidradenitis suppurativa, a chronic inflammatory skin disease, to review and evaluate the evidence. They report that most available treatments lack high-quality evidence and recommend future trials use validated scores, patient-rated outcomes, and thorough reporting of side effects.
- Who or what was studied
- Patients with hidradenitis suppurativa
- Limits stated in the abstract
- The abstract states that most available treatment modalities lack high-quality evidence, and it does not report the number of trials or participants included.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.